J Korean Diabetes Assoc.  2006 Nov;30(6):428-434.

Role of Glucocorticoid Receptor on Insulin Secretion and Synthesis in INS-1 Cells

• Yang JY
• Kang MS
• Song TH
• Jeong IK
• Seo PJ
• Kim HJ

Abstract

BACKGROUND: Glucocorticoids play important roles in the regulation of glucose homeostasis. It is well known that glucocorticoids reduce hepatic and peripheral tissue sensitivity to insulin, but the roles of glucocorticoids on insulin secretion and synthesis in pancreatic beta cells are still unclear. We have investigated the direct effects of glucocorticoids on insulin secretion and synthesis in rat insulinoma (INS-1) cells.
METHODS
Insulin content and 11.2 mM glucose-stimulated insulin secretion (GSIS) were measured in INS-1 cells after culture with or without 1 micrometer dexamethasone (DEX). Preproinsulin mRNA levels were analyzed by real-time RT-PCR and normalized to the internal control. Effect of RU486 on DEX-induced inhibition of GSIS and preproinsulin mRNA synthesis was evaluated.
RESULTS
Insulin content of INS-1 cells cultured in RPMI containing 11.2 mM glucose in the presence of DEX was not different from that of control cells. After 1-h preincubation in 2.8 mM glucose, basal insulin secretion from cells treated with DEX did not differ from that of controls, but GSIS was significantly reduced in the cells treated with DEX in comparison to control cells. The expression of preproinsulin mRNA relative to beta-actin mRNA was also lower in the cells treated with DEX. Glucocorticoid receptor antagonist improved DEX-induced inhibition of GSIS and preproinsulin mRNA synthesis.
CONCLUSION
DEX inhibited GSIS and preproinsulin mRNA synthesis in INS-1 cells. Glucocorticoid receptor antagonist ameliorated the reduced GSIS and preproinsulin mRNA synthesis induced by DEX.

Keyword

Beta cell; Dexamethasone; Glucocorticoids; Glucocorticoid receptor antagonists; Insulin Secretion; Insulin Synthesis; RU486

MeSH Terms

Actins
Animals
Dexamethasone
Glucocorticoids
Glucose
Homeostasis
Insulin*
Insulin-Secreting Cells
Insulinoma
Mifepristone
Rats
Receptors, Glucocorticoid*
RNA, Messenger
Actins
Dexamethasone
Glucocorticoids
Glucose
Insulin
Mifepristone
RNA, Messenger
Receptors, Glucocorticoid

Figure

• 

  Fig. 1 Effect of dexamethasone (DEX) on intracellular insulin content in INS-1 cells. Insulin content was measured from the lysates of INS-1 cells cultured in RPMI containing 11.1 mM glucose in the absence (white bar) or presence (black bar) of DEX for 1 day and 2 days. Insulin amount was normalized by total protein amount in the cell lysates. Values are means ± SEM.

• 

  Fig. 2 Effect of DEX on glucose-stimulated insulin secretion (GSIS) in INS-1 cells. GSIS was evaluated from INS-1 cells in the absence (white bar) or presence (black bar) of DEX for 1 day (A) and 2 days (B). The amount of secreted insulin was normalized by total protein amount in the cell lysates. In the cells cultured with DEX, basal insulin secretion (2.8 mM) did not differ from that of controls, but GSIS (11.2 mM) was significantly decreased in comparison to control cells. *p < 0.05 versus cells in 2.8 mM glucose. †p < 0.05 versus cells with vehicle in 11.2 mM glucose.

• 

  Fig. 3 Effect of RU486 on DEX-induced inhibition of insulin secretion in INS-1 cells. The cells were cultured with or withiout RU486 in the presence or absence of DEX for 2 days and glucose-stimulated insulin secretion was measured by rat insulin radioimmunoassay. The amount of secreted insulin was normalized by total protein amount in the cell lysates. Values are means ± SEM. *p < 0.05 versus cells with DEX in 11.2 mM glucose.

• 

  Fig. 4 Effect of DEX and RU486 on preproinsulin mRNA in INS-1 cells. After the cells were cultured with or withiout RU486 in the absence (white bar) or presence (black bar) of DEX for 2 days, preincubated in 2.8 mM KRBB-HEPES for 2 hours, and then cultured in KRBB-HEPES containing 2.8 mM and 11.2 mM glucose for 3 hours. The expression levels of preproinsulin mRNA and beta-actin were analyzed by real-time RT-PCR. The preproinsulin mRNA expression was normalized to beta-actin mRNA expression in the corresponding sample. Values are means ± SEM. *p < 0.05 versus cells with vehicle in 2.8 mM glucose.

Reference

1. McMahon M, Gerich J, Rizza R. Effects of glucocorticoids on carbohydrate metabolism. Diabetes Metab Rev. 1988. 4:17–30.

2. Hirsch IB, Paauw DS. Diabetes management in special situations. Endocrinol Metab Clin North Am. 1997. 26:631–645.

3. Andrews RC, Walker BR. Glucocorticoids and insulin resistance: old hormones, new targets. Clin Sci. 1999. 96:513–523.

4. Tappy L, Randin D, Vollenweider P, Vollenweider L, Paquot N, Scherrer U, Schneiter P, Nicod P, Jequier E. Mechanisms of dexamethasone-induced insulin resistance in healthy humans. J Clin Endocrinol Metab. 1994. 79:1063–1069.

5. Coderre L, Srivastava AK, Chiasson JL. Effect of hypercorticism on regulation of skeletal muscle glycogen metabolism by insulin. Am J Physiol. 1992. 262:E427–E433.

6. Owen OE, Cahill GF Jr. Metabolic effects of exogenous glucocorticoids in fasted man. J Clin Invest. 1973. 52:2596–2605.

7. Hollingdal M, Juhl CB, Dall R, Sturis J, Veldhuis JD, Schmitz O, Porksen N. Glucocorticoid induced insulin resistance impairs basal but not glucose entrained high-frequency insulin pulsatility in humans. Diabetologia. 2002. 45:49–55.

8. Wajngot A, Giacca A, Grill V, Vranic M, Efendic S. The diabetogenic effects of glucocorticoids are more pronounced in low- than in high-insulin responders. Proc Natl Acad Sci USA. 1992. 89:6035–6039.

9. Henriksen JE, Alford F, Ward GM, Beck-Nielsen H. Risk and mechanism of dexamethasone-induced deterioration of glucose tolerance in non-diabetic first-degree relatives of NIDDM patients. Diabetologia. 1997. 40:1439–1448.

10. Lambillotte C, Gilon P, Henquin JC. Direct Glucocorticoid Inhibition of Insulin Secretion-An In Vitro Study of Dexamethasone Effects in Mouse Islets. J Clin Invest. 1997. 99:414–423.

11. Delaunay F, Khan A, Cintra A, Davani B, Ling ZC, Andersson A, Ostenson CG, Gustafsson J, Efendic S, Okret S. Pancreatic beta cells are important targets for the diabetogenic effects of glucocorticoids. J Clin Invest. 1997. 100:2094–2098.

12. Jeong IK, Oh SH, Kim BJ, Chung JH, Min YK, Lee MS, Lee MK, Kim KW. The effects of dexamethasone on insulin release and biosynthesis are dependent on the dose and duration of treatment. Diabetes Res Clin Pract. 2001. 51:163–171.

13. Asfari M, Janjic D, Meda P, Li G, Halban PA, Wollheim CB. Establishment of 2-mercaptoethanol-dependent differentiated insulin-secreting cell lines. Endocrinology. 1992. 130:167–178.

14. Biering H, Knappe G, Gerl H, Lochs H. Prevalence of diabetes in acromegaly and Cushing syndrome. Acta Med Austriaca. 2000. 27:27–31.

15. Boscaro M, Barzon L, Fallo F, Sonino N. Cushing's syndrome. Lancet. 2001. 357:783–791.

16. Pagano G, Cavallo-Perin P, Cassader M, Bruno A, Ozzello A, Masciola P, Dall'omo AM, Imbimbo B. An in vivo and in vitro study of the mechanism of prednisone-induced insulin resistance in healthy subjects. J Clin Invest. 1983. 72:1814–1820.

17. Stojanovska L, Rosella G, Proietto J. Dexamethasone-induced increase in the rate of appearance in plasma of gut-derived glucose following an oral glucose load in rats. Metabolism. 1991. 40:297–301.

18. Karlsson S, Ostlund B, Myrsen-Axcrona U, Sundler F, Ahren B. Beta cell adaptation to dexamethasone-induced insulin resistance in rats involves increased glucose responsiveness but not glucose effectiveness. Pancreas. 2001. 22:148–156.

19. Chuthaputti A, Fletcher HP. Effect of hydrocortisone on terbutaline stimulated insulin release from isolatedpancreatic islets. Res Commun Chem Pathol Pharmacol. 1987. 57:329–341.

20. Brunstedt J, Nielsen JH. Direct long-term effect of hydrocortisone on insulin and glucagon release from mouse pancreatic islets in tissue culture. Acta Endocrinol. 1981. 96:498–504.

21. Fernandez-Mejia C, Davidson MB. Regulation of glucokinase and proinsulin gene expression and insulin secretion in RIN-m5F cells by dexamethasone, retinoic acid, and thyroid hormone. Endocrinology. 1992. 130:1660–1668.

22. Schoneveld OJ, Gaemers IC, Lamers WH. Mechanisms of glucocorticoid signalling. Biochim Biophys Acta. 2004. 1680:114–128.

23. Zhou J, Cidlowski JA. The human glucocorticoid receptor: one gene, multiple proteins and diverse responses. Steroids. 2005. 70:407–417.

24. Buttgereit F, Brand MD, Burmester GR. Equivalent doses and relative drug potencies for non-genomic glucocorticoid effects: a novel glucocorticoid hierarchy. Biochem Pharmacol. 1999. 58:363–368.

25. Sitruk-Ware R, Spitz IM. Pharmacological properties of mifepristone: toxicology and safety in animal and human studies. Contraception. 2003. 68:409–420.

26. Gremlich S, Roduit R, Thorens B. Dexamethasone induces posttranslational degradation of GLUT2 and inhibition of insulin secretion in isolated pancreatic beta cells. Comparison with the effects of fatty acids. J Biol Chem. 1997. 272:3216–3222.

27. Shinozuka Y, Okada M, Oki T, Sagane K, Mizui Y, Tanaka I, Katayama K, Murakami-Murofushi K. Altered Expression of HES-1, BETA2/NeuroD, and PDX-1 Is Involved in Impaired Insulin Synthesis Induced by Glucocorticoids in HIT-T15 Cells. Biochem Biophys Res Commun. 2001. 287:229–235.